Skip to main content

Table 3 Factors influencing purchases higher than the lowest and the highest direct manufactured costs

From: Factors influencing global antiretroviral procurement prices

  More than lowest direct manufactured costs More than highest direct manufactured costs
  Odds ratio p-value Lower
95%CI
Upper
95%CI
Odds ratio p-value Lower
95% CI
Upper
95% CI
HIV prevelence < 2% 1     1    
HIV Prevelence 2-5% 0.75 0.174 0.50 1.13 1.17 0.389 0.81 1.70
HIV Prevalence >5% 0.86 0.300 0.65 1.14 1.36 0.103 0.94 1.97
Low income 1     1    
Lower-middle income 1.43 0.079 0.96 2.14 1.63 0.010 1.13 2.37
Upper-middle income 4.05 0.000 2.23 7.34 2.02 0.003 1.27 3.23
PI* 0.99 0.311 0.98 1.00 0.99 0.480 0.98 1.00
Volume 1 st tercile 1     1    
Volume 2 nd tercile 0.76 0.211 0.50 1.17 1.28 0.060 0.99 1.65
Volume 3 th tercile 0.56 0.016 0.35 0.90 0.69 0.055 0.48 1.01
Innovator 4.01 0.003 1.60 10.45 6.10 0.000 3.09 12.05
CHAI** 0.77 0.255 0.49 1.20 0.53 0.001 0.36 0.77
PEPFAR*** 0.88 0.482 0.61 1.26 1.27 0.143 0.92 1.75
Pseudo R2 0.0994     0.1752    
Number of obs 9161     9161    
  1. *API = AIDS Program Effort Index; **CHAI = Clinton Foundation HIV/AIDS Initiative; ***PEPFAR = President's Emergency Plan for AIDS Relief.
  2. Data source: Global Price Reporting Mechanism 2005 to 2008